Sarepta Therapeutics (SRPT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2017 | 03-2017 | 12-2016 | 09-2016 | 06-2016 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 21,044 | 84,090 | -267,265 | -178,813 | -122,071 |
| Depreciation Amortization | 3,149 | 1,537 | 5,691 | 4,420 | 3,267 |
| Accounts receivable | -12,563 | -7,050 | -1,251 | -9 | -5 |
| Other Working Capital | -59,126 | -24,794 | -15,767 | -13,836 | 1,143 |
| Other Operating Activity | -95,539 | -111,671 | 32,772 | 23,651 | 13,694 |
| Operating Cash Flow | $-143,035 | $-57,888 | $-245,820 | $-164,587 | $-103,972 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 63,173 | 80,000 | -83,327 | 112,101 | 100,712 |
| PPE Investments | -7,336 | -4,465 | -5,341 | -2,427 | -1,587 |
| Sale Of Investment | 10,695 | 10,695 | N/A | 0 | 0 |
| Purchase Sale Intangibles | 123,399 | 123,755 | -1,525 | -1,093 | -768 |
| Other Investing Activity | 123,399 | 123,755 | -1,525 | -1,093 | -768 |
| Investing Cash Flow | $189,931 | $209,985 | $-90,193 | $108,581 | $98,357 |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | -5,054 | -2,543 | -7,603 | -5,076 | -2,551 |
| Common Stock Issued | 4,086 | 2,749 | 385,732 | 375,918 | 39,681 |
| Financing Cash Flow | $-968 | $206 | $378,129 | $370,842 | $37,130 |
| Beginning Cash Position | 122,556 | 122,556 | 80,440 | 80,440 | 80,439 |
| End Cash Position | 168,484 | 274,859 | 122,556 | 395,276 | 111,954 |
| Net Cash Flow | $45,928 | $152,303 | $42,116 | $314,836 | $31,515 |
| Free Cash Flow | |||||
| Operating Cash Flow | -143,035 | -57,888 | -245,820 | -164,587 | -103,972 |
| Capital Expenditure | -7,336 | -4,465 | -5,341 | -2,427 | -1,587 |
| Free Cash Flow | -150,371 | -62,353 | -251,161 | -167,014 | -105,559 |